Received Nov 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (VAQTA) | MERCK & CO. INC. | 3 | Y007585 | — |
| HEPA | HEP A (VAQTA) | MERCK & CO. INC. | 1 | — | — |
| HEPA | HEP A (VAQTA) | MERCK & CO. INC. | 2 | — | — |
no additional AE; expired VAQTA was administered; received 2 doses already, July 2015, Dec 2015; This spontaneous report was received from an Other health professional and referred to an 11-year-old male patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On an unknown date in July 2015, the patient was vaccinated with the first dose of Hepatitis A Vaccine, Inactivated Suspension for injection (VAQTA),1 dosage form, total (lot # and expiration date were not reported) for prophylaxis. On an unknown date in December 2015, the patient was vaccinated with the second dose of Hepatitis A Vaccine, Inactivated Suspension for injection (VAQTA), 1 dosage form, total (lot # and expiration date were not reported) (Inappropriate schedule of vaccine administered) On 03-Nov-2025, the patient was vaccinated with the third dose of expired Hepatitis A Vaccine, Inactivated Suspension for injection (VAQTA) (lot #Y007585, expiration date: 31-Oct-2025), (0.5mL/third dose) for prophylaxis (Expired product administered). There was no additional AE. The action taken with Hepatitis A Vaccine, Inactivated Suspension for injection (VAQTA) was not applicable.